Fifty 1 Labs, Inc. (FITY)

Ligand Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Mar 31, 2011	Jun 30, 2010	Jun 30, 2009	Jun 30, 2008	Jun 30, 2007	Jun 30, 2006
Operating Revenue	2.92	3.94	4.4	3.43	6.94	11.68
Other Revenue	1.15	1.17	1.01	1.07	-	-
Revenue	4.08	5.11	5.41	4.51	6.94	11.68
Revenue Growth (YoY)	-29.40%	-5.64%	20.10%	-35.11%	-40.57%	458.26%
Cost of Revenue	1.49	2.16	2.95	2.59	4.21	7.99
Gross Profit	2.58	2.95	2.46	1.91	2.73	3.7
Selling, General & Admin	3.52	3.8	3.8	3.17	4.81	3.24
Operating Expenses	3.52	3.8	3.8	3.17	4.81	3.24
Operating Income	-0.93	-0.85	-1.34	-1.26	-2.07	0.45
Interest Expense	-1.17	-1.04	-0.89	-0.85	-	-
Other Non Operating Income (Expenses)	-	-	0	-	-	-0.21
EBT Excluding Unusual Items	-2.1	-1.89	-2.23	-2.1	-2.07	0.24
Impairment of Goodwill	-	-	-	-	-0.21	-0.69
Pretax Income	-2.1	-1.89	-2.23	-2.1	-2.29	-0.45
Net Income	-2.1	-1.89	-2.23	-2.1	-2.29	-0.45
Net Income to Common	-2.1	-1.89	-2.23	-2.1	-2.29	-0.45
Shares Outstanding (Basic)	9	9	9	10	10	10
Shares Outstanding (Diluted)	9	9	9	10	10	10
Shares Change (YoY)	3.82%	-	-4.57%	-0.11%	-	1.82%
EPS (Basic)	-0.22	-0.20	-0.24	-0.21	-0.23	-0.05
EPS (Diluted)	-0.22	-0.20	-0.24	-0.21	-0.23	-0.05
Free Cash Flow	-1.57	-1.63	-1.63	-0.97	-3.14	-3.02
Free Cash Flow Per Share	-0.17	-0.17	-0.17	-0.10	-0.32	-0.31
Gross Margin	63.37%	57.74%	45.44%	42.43%	39.38%	31.63%
Operating Margin	-22.93%	-16.71%	-24.82%	-27.87%	-29.87%	3.88%
Profit Margin	-51.56%	-37.09%	-41.23%	-46.66%	-32.93%	-3.83%
Free Cash Flow Margin	-38.57%	-31.85%	-30.06%	-21.50%	-45.19%	-25.86%
EBITDA	-0.92	-0.83	-1.33	-1.25	-2.06	0.5
EBITDA Margin	-22.52%	-16.32%	-24.64%	-27.63%	-29.64%	4.31%
D&A For EBITDA	0.02	0.02	0.01	0.01	0.02	0.05
EBIT	-0.93	-0.85	-1.34	-1.26	-2.07	0.45
EBIT Margin	-22.93%	-16.71%	-24.82%	-27.87%	-29.87%	3.88%
Revenue as Reported	4.08	5.11	5.41	4.51	-	-
Advertising Expenses	-	-	-	-	0.07	0.27

Updated May 16, 2011. Source: S&P Global Market Intelligence. Standard template. Financial Sources.